medRxiv PreprintsInternational6 October 2026
Leveraging Skin Mutagenesis to Uncover Genetic Cancer Susceptibilities
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Identifying inherited cancer predisposition genes remains challenging. We leveraged the skin's high UV-mutagenic burden to discover susceptibility genes by studying patients with high frequency of basal cell carcinomas (hfBCC). We found that hfBCC patients had three-fold higher internal malignancy prevalence and identified a novel candidate EPHB2 cancer susceptibility mutation associated with BCC and prostate cancer. These findings demonstrate the skin's potential as a powerful platform for discovering cancer predisposition variants.
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Acquisition Speed versus Spatial Resolution in Ultra-High-Resolution Photon-Counting CT: Phantom Study to Guide Protocol Development6 October 2026
- Predicting Cervical Cancer Screening Utilization Among Women of Reproductive Age in Ethiopia Using Supervised Machine Learning: A Nationally Representative 2024/25 EDHS Study6 October 2026
- Overdose-related communication in Connecticut: reported receipt, perceived utility, and responses among overdose prevention and response professionals6 October 2026
- Diabetes Polygenic Scores Predict Glycemic Indices and Insulin Use in Individuals with Atypical Diabetes6 October 2026
- Right Versus Left Ventricular Myofiber Orientation in Various Congenital Heart Diseases Analyzed with X-Ray Phase-Contrast Tomography6 October 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.